Some melanoma patients respond very well to immunotherapy, experiencing profound and durable tumor regression. A fraction of these patients will also develop autoimmunity against their normal melanocytes—the cells that ...
Mar 24, 2021
0
176
Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) is the first cancer center in the world to install BeamSite Cherenkov imaging cameras in its radiotherapy treatment rooms. The camera system, invented, ...
Feb 5, 2021
0
12
A joint team of researchers from Radiation Oncology at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC), Dartmouth Engineering, and Dartmouth-Hitchcock's Department of Surgery have developed a method ...
Jan 19, 2021
0
4
A key hurdle in treating breast cancers is intratumoral heterogeneity, or the presence of multiple different cell populations within the same tumor that have distinct characteristics such as gene expression, metabolism and ...
Oct 28, 2020
0
7
Genomic mutation testing is critical to therapeutic selection and management of patients with colorectal cancer. In a new multicenter study, researchers compared a new cartridge-based laboratory testing device called the ...
Jun 26, 2020
0
0
The development of pancreatic cancer is driven by co-existing mutations in an oncogene involved in controlling cell growth, called KRAS, and in a tumor suppressor gene, called p53. But how these mutations cooperate to promote ...
Jun 18, 2020
0
94
A research team at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center has found that the same vaccination programs that target human papillomavirus (hrHPV) strains in the United States may not be as effective ...
Jun 4, 2020
0
0
Colorectal cancer is estimated to cause more than 53,000 deaths in the US in 2020, making it the second most common cause of cancer death. This death rate, however, has been steadily dropping, likely due to better cancer ...
Apr 23, 2020
0
67
Most breast cancers utilize the female hormone estrogen to grow, so drug-induced estrogen deprivation is used as a treatment in many patients. However, cancer will recur in one-third of these patients. A research team at ...
Apr 22, 2020
0
0
The burden of cancer is on the rise in low- and middle-income countries (LMICs) such as Honduras. Few people in rural Honduras have access to cancer screening of any kind. A research team comprised of Honduran oncologists ...
Mar 11, 2020
0
1
